Kyntra Bio (KYNB)

• Market cap: $27.4M
• 1 day: 1.05%
• 5 days: -0.59%
• 1 month: -0.59%
• 3 months: -5.06%
• 6 months: -22.3%
• Year to date: -26.2%
• 1 year: -12.55%
• 5 years: -98.96%
• 10 years: -98.39%
• Sector: Healthcare
• Industry: Biotechnology

About: Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Employees: 34